AI Can Find Revenue. But Can It Defend It?

Tech-enabled revenue integrity requires more than AI: Why CFOs should prioritize clinical expertise

Health system CFOs are under pressure to improve financial performance without adding operational burden, compliance exposure, or denial risk.

AI can help identify revenue opportunities at scale. But identifying an opportunity is not the same as proving it is clinically supported, accurately coded, and defensible under payer review.

That distinction matters.

Enjoin’s technology-enabled, physician-directed model pairs advanced analytics with expert clinical validation to prioritize high-value opportunities, support accurate reimbursement, and reduce downstream denial risk.

Our latest case study explores why CFOs should think beyond AI-only approaches — and why clinically grounded revenue integrity matters more than ever.